A detailed history of Alaska Permanent Fund Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Alaska Permanent Fund Corp holds 2,493 shares of NVO stock, worth $317,932. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,493
Previous 3,088 19.27%
Holding current value
$317,932
Previous $396,000 10.35%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$122.71 - $146.91 $73,012 - $87,411
-595 Reduced 19.27%
2,493 $355,000
Q1 2024

Apr 09, 2024

BUY
$102.11 - $135.92 $315,315 - $419,720
3,088 New
3,088 $396,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $288B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Alaska Permanent Fund Corp Portfolio

Follow Alaska Permanent Fund Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.